Omniab Inc Revenue Growth Rates (OABI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Omniab Inc   (NASDAQ: OABI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

OABI's Revenue Growth by Quarter and Year

Omniab Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OABI Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 13.42
1st Quarter March 14.43
FY 27.85





OABI Revenue second quarter 2026 Y/Y Growth Comment
Omniab Inc achieved in the second quarter 2026, above Company average Revenue surge of 243.97% year on year, to $ 13.42 millions.

Looking into second quarter 2026 results within Medical Laboratories industry 27 other companies have achieved higher Revenue growth. While Omniab Inc ' s Revenue doubling of 243.97% ranks overall at the positon no. 3280 in the second quarter 2026.


OABI Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -22.41 % 124.07 % -86.36 %
3rd Quarter September - -46.28 % -23.91 % -20.69 %
2nd Quarter June 243.97 % -48.75 % 9.5 % -3.47 %
1st Quarter March 247.71 % 9.21 % -77.54 % 75.88 %
FY   - -29.23 % -22.8 % -

Financial Statements
Omniab Inc 's second quarter 2026 Revenue $ 13.42 millions OABI's Income Statement
Omniab Inc 's second quarter 2025 Revenue $ 3.90 millions Quarterly OABI's Income Statement


OABI Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 274.11 % 158.99 % -12.04 %
3rd Quarter September - -42.56 % -45.2 % -21.15 %
2nd Quarter June -7.03 % -6.02 % 100.26 % -58.92 %
1st Quarter March 72.2 % -61.57 % -21.16 % -52.14 %
FY (Year on Year)   - -29.23 % -22.8 % -


Back to OABI Growth rate Comparisons >> Back to OABI Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #28
Healthcare Sector #439
Overall #3280

Revenue Y/Y Growth Statistics
High Average Low
67.01 % -16.95 % -68.45 %
(Jun 30 2026)   (Sep 30 2024)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #28
Healthcare Sector #439
Overall #3280
Revenue Y/Y Growth Statistics
High Average Low
67.01 % -16.95 % -68.45 %
(Jun 30 2026)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Omniab Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
411.51 % 38.83 % -61.55 %
(Dec 31 2022)  


OABI's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Omniab Inc disclosed drop in Revenue from the first quarter by -7.03% to $ 13.42 millions, from $ 14.43 millions achived in the previous reporting period.

But that's not important problem, as Omniab Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Laboratories industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Omniab Inc 's Revenue growth quarter on quarter, overall rank is 2646.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #23
Healthcare Sector #328
Overall #2646
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #23
Healthcare Sector #328
Overall #2646
Revenue Q/Q Growth Statistics
High Average Low
411.51 % 38.83 % -61.55 %
(Dec 31 2022)  


OABI's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Omniab Inc disclosed drop in Revenue from the first quarter by -7.03% to $ 13.42 millions, from $ 14.43 millions achived in the previous reporting period.

But that's not important problem, as Omniab Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Laboratories industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Omniab Inc 's Revenue growth quarter on quarter, overall rank is 2646.


Omniab Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 38.46 $ 28.94 $ 18.67 $ 21.09 $ 23.03
Y / Y Revenue Growth (TTM) 67.01 % 8.21 % -29.27 % 3.36 % 6.05 %
Year on Year Revenue Growth Overall Ranking # 1957 # 2333 # 2259 # 1516 # 3199
Seqeuential Revenue Change (TTM) 32.89 % 55.04 % -11.51 % -8.39 % -13.9 %
Seq. Revenue Growth (TTM) Overall Ranking # 3306 # 306 # 1943 # 880 # 2713


Cumulative Revenue growth Comment
With 67.01% annual Revenue growth, Omniab Inc would report a record annual Revenue growth if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 301 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1957, from total ranking in previous quarter at 2333.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 302
Overall # 1957

Revenue TTM Y/Y Growth Statistics
High Average Low
67.01 %
 -16.95 %
-68.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 440
S&P 500 # 3306
Cumulative Revenue growth Comment
With 67.01% annual Revenue growth, Omniab Inc would report a record annual Revenue growth if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 301 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1957, from total ranking in previous quarter at 2333.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 302
Overall # 1957

Revenue TTM Y/Y Growth Statistics
High Average Low
67.01 %
-16.95 %
-68.45 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 440
S&P 500 # 3306




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OABI's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Surrozen Inc 408.65%$ 408.647 millions
Regenxbio Inc 405.73%$ 405.731 millions
Insmed Inc393.78%$ 393.775 millions
Omeros Corporation387.10%$ 387.096 millions
Catheter Precision Inc 380.66%$ 380.660 millions
Macrogenics Inc 377.97%$ 377.974 millions
Vireo Growth Inc.335.47%$ 335.470 millions
Dianthus Therapeutics Inc 294.30%$ 294.301 millions
Miragen Therapeutics Inc 278.67%$ 278.667 millions
Alpha Cognition Inc.267.56%$ 267.556 millions
Agios Pharmaceuticals Inc 259.25%$ 259.253 millions
Omniab Inc 244.24%$ 244.239 millions
Medicinova Inc 240.60%$ 240.596 millions
Clene Inc 233.33%$ 233.333 millions
Editas Medicine Inc 232.31%$ 232.309 millions
Urogen Pharma Ltd 206.17%$ 206.174 millions
Sintx Technologies Inc 199.34%$ 199.338 millions
Arrowhead Pharmaceuticals Inc 171.02%$ 171.016 millions
Cue Biopharma Inc 166.66%$ 166.655 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________162.99%$ 162.992 millions
Cormedix Inc 156.52%$ 156.515 millions
Ataibeckley Inc 137.00%$ 136.996 millions
Pavmed Inc 135.71%$ 135.714 millions
Xilio Therapeutics Inc 131.22%$ 131.222 millions
Tenon Medical Inc 126.77%$ 126.773 millions
Sonida Senior Living Inc 122.02%$ 122.024 millions


About Omniab Inc Revenue Growth Rates (OABI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Omniab Inc (CIK 1846253).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001846253-26-000046
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Omniab Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.